US health insurers slide as final Medicare Advantage rate sparks margin hit fears

Send a link to a friend  Share

[April 02, 2024]  (Reuters) - Shares of U.S. health insurers dropped between 4% and 9% premarket on Tuesday after reimbursement rates to providers of Medicare Advantage health plans were unchanged from the initial proposal, raising worries about a squeeze on margins next year.  

The corporate logo of the UnitedHealth Group appears on the side of one of their office buildings in Santa Ana, California, U.S., April 13, 2020. REUTERS/Mike Blake/File Photo

The U.S. Centers for Medicare & Medicaid Services (CMS) payments to Medicare Advantage (MA) programs, which serve those aged 65 and older, are expected to increase by 3.7% on average in 2025, consistent with what was published in January.

Excluding some items, the rate implies a drop of 0.16%, some analysts have estimated. The CMS typically raises the final reimbursement from the advanced notice.

"With most anticipating some improvement in the effective growth rate," the rates come as a disappointment for companies operating in the Medicare Advantage market who are likely to see continued margin pressure, Evercore ISI analysts said in a note.

The "no improvement represented our worst-case scenario," TD Cowen analysts wrote in a note.

Leading the decline was Humana, slumping 8.8%, as its business is focused on the Medicare Advantage market.

UnitedHealth fell 4%, while CVS Health tumbled 5%.

The closely watched proposal decides how much insurers can charge for monthly premiums, plan benefits they offer and, ultimately, their profits.

(Reporting by Medha Singh and Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

[© 2024 Thomson Reuters. All rights reserved.]
This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.

 

 

Back to top